Twelve Swiss startups join Euronext’s Pre-Ipo programme Techshare


The 5th edition of the Techshare program will kick off on 20th September at the Erasmus Centre for Entrepreneurship in the Netherlands. Twelve Swiss startups are participating in the eight months program.


Euronext, the pan-European stock exchange, will launch its annual TechShare programme on 20/21 September 2019. Techshare is a training programme for potential future IPO candidates. The eigh-months program, from September 2019 to April 2020, provides a platform, tools and insights that will help prepare companies for their next step towards the IPO. In its fifth edition, the program welcomes 132 tech companies from nine countries at Rotterdam’s Erasmus Centre for Entrepreneurship to kick-off the programme. Among the participants are twelve Swiss startups. Seven of the 12 selected Swiss participants have been revealed. They  include; CreditGate24 – is a peer-peer-lending platform for the financing of private and business loans. Today the platform has funded 150 million loans in Switzerland. The company has raised 6 million in a financing round and employs 25 employees.  NetGuardians – developed a unique approach to fraud and risk assurance solutions. Their software leverages Big Data to correlate and analyze behaviours across the entire bank system – not just at the transaction level. With automated controls, NetGuardians enables banks to target specific anti-fraud or regulatory requirements. the company is active in several continents including North America, Asia and Africa. InSphero – offers comprehensive solutions for preclinical drug safety and efficacy testing based on 3D microtissues, which are phenotypic models of the smallest functional unit of a tissue or organ. These drug-discovery and testing platforms combine scalable 3D technology, ISO quality-controlled 3D human tissue models, 3D-optimized media, as well as tailored assay services and support. With its recently launched 3D InSight Human Liver Disease Discovery Platform, Insphero brought a breakthrough in 3D cell technology for drug discovery and safety testing. Legacy Healthcare – the Lausanne based startup is specialized in the development of innovative botanical drugs in Immuno-Dermatology, Dermatology and Oncology supportive care. With its lean platform, the company has already built up a pipeline of 3 drug candidates in 6 different indications and two science-backed cosmetic products are already on the market, generating revenue. Deon Digital – the startup leverages its more than 10 years of academic research, R&D team, and the power of distributed ledger technology to turn paper contracts into automatically managed digital contracts. Deon Digital technology stores, executes and monitors digital contracts securely, privately, and automatically.  It dramatically reduces the amount of human and economic resources lost in translation from company strategy to contracts to verified IT systems. Gondola Medical Technologies – developed Gondola, a portable medical device for personal use, made for people who live with Parkinson’s Disease able to reduce motor symptoms and to improve balance. Nomoko -  is developing an extremely precise 3D digital twin of the world hosted on a platform allowing to integrate other spatial information. The digital world called «Mirror World» will provide access to many innovations in the automotive field, including self- driving algorithms, Smart Cities and virtual reality at the city level.   (RAN)